Málta - angol - Medicines Authority

nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - zinc oxide, benzyl alcohol, benzyl benzoate, benzyl cinnamate, lanolin - cream - benzyl cinnamate 0.15 % (w/w) benzyl alcohol 0.39 % (w/w) zinc oxide 15.25 % (w/w) lanolin 4 % (w/w) benzyl benzoate 1.01 % (w/w) - emollients and protectives

Egyesült Államok - angol - NLM (National Library of Medicine)

aurobindo pharma limited - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - concomitant administration with strong p450 inducers, such as rifampin, are contraindicated since the efficacy of nifedipine tablets could be significantly reduced. (see precautions, drug interactions. ) nifedipine must not be used in cases of cardiogenic shock. nifedipine extended-release tablets are contraindicated in patients with a known hypersensitivity to any component of the tablet.

Európai Unió - angol - EMA (European Medicines Agency)

ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - pituitary and hypothalamic hormones and analogues - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),

Egyesült Államok - angol - NLM (National Library of Medicine)

aurobindo pharma limited - hydroxyzine dihydrochloride (unii: 76755771u3) (hydroxyzine - unii:30s50ym8og) - for symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses and in histamine-mediated pruritus. as a sedative when used as a premedication and following general anesthesia, hydroxyzine may potentiate meperidine and barbiturates , so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. atropine and other belladonna alkaloids are not affected by the drug. hydroxyzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent. the effectiveness of hydroxyzine as an antianxiety agent for long term use, that is more than 4 months, has not been assessed by systematic clinical studies. the physician should reassess periodically the usefulness of the drug for the individual patient. oral hydroxyzine hydrochloride

Egyesült Államok - angol - NLM (National Library of Medicine)

alembic pharmaceuticals inc. - doxepin hydrochloride (unii: 3u9a0fe9n5) (doxepin - unii:5asj6huz7d) - doxepin hydrochloride capsules are recommended for the treatment of: - psychoneurotic patients with depression and/or anxiety. - depression and/or anxiety associated with alcoholism (not to be taken concomitantly with alcohol). - depression and/or anxiety associated with organic disease (the possibility of drug interaction should be considered if the patient is receiving other drugs concomitantly). - psychotic depressive disorders with associated anxiety including involutional depression and manic-depressive disorders. the target symptoms of psychoneurosis that respond particularly well to doxepin hydrochloride capsules include anxiety, tension, depression, somatic symptoms and concerns, sleep disturbances, guilt, lack of energy, fear, apprehension and worry. clinical experience has shown that doxepin hydrochloride capsule is safe and well tolerated even in the elderly patient. owing to lack of clinical experience in the pediatric population, doxepin hydrochloride capsule is not recommended for use in childre

Írország - angol - HPRA (Health Products Regulatory Authority)

chefaro ireland dac - chloroxylenol; tcp liquid antiseptic ; triclosan - cream - 25 %w/w+0.5%w/w+ 0.3 percent weight/weight - phenol and derivatives; phenol; triclosan; chloroxylenol; salicylic acid and derivatives; sodium salicylate

Egyesült Államok - angol - NLM (National Library of Medicine)

alembic pharmaceuticals limited - acetazolamide (unii: o3fx965v0i) (acetazolamide - unii:o3fx965v0i) - for adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma,  and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to  lower intraocular pressure. acetazolamide extended-release capsules are also indicated for the prevention or amelioration of  symptoms associated with acute mountain sickness despite gradual  ascent. hypersensitivity to acetazolamide or any excipients in the formulation. since acetazolamide is  a sulfonamide derivative, cross sensitivity between acetazolamide, sulfonamides and other  sulfonamide derivatives is  possible. acetazolamide therapy is contraindicated in situations in which sodium and/or potassium blood  serum levels are depressed, in cases of marked kidney and liver disease or dysfunction, in suprarenal  gland failure, and in hyperchloremic acidosis. it is contraindicated in patients with cirrhosis because of  the risk of development of hepatic  encephalopathy. long-term administration of acetazolamide extended-rele

Tanzánia - angol - Tanzania Medicinces & Medical Devices Authority

core pharma limited, tanzania - disodium hydrogen citrate - solution, oral - 1.37 g/5ml

Tanzánia - angol - Tanzania Medicinces & Medical Devices Authority

core pharma limited, tanzania - disodium hydrogen citrate - solution, oral - 1.37 g/5ml

Tanzánia - angol - Tanzania Medicinces & Medical Devices Authority

aurobindo pharma limited, india - dutasteride,tamsulosin hydrochloride - capsules - 0.5/0.4